![]() The QuickVue® At-Home OTC COVID-19 Test allows consumers to easily perform the test themselves without a doctor’s prescription and get results in 10 minutes from nasal swab samples. We look forward to sharing more on these and other initiatives in the future but can report with confidence today that there continues to be both a strong need for COVID testing and an opportunity for us to do our part.” Bryant concluded, “Additionally, in the quarter and consistent with our strategy to expand access to affordable testing, we have been working with educational institutions to provide free diagnostic product in underserved communities. If we have learned anything over the past 18-months, it is that while the testing environment has been, and remains fluid, it is wise to further invest in, and enhance, our agility as the landscape continues to evolve.” ![]() As a result, over the last month, we have experienced a marked increase in SARS category revenues for the third quarter-to-date 2021 and have surpassed the total COVID-related revenue in the second quarter of 2021. ![]() Bryant added, “Thanks to our stay-the-course strategy and ever-expanding footprint in the professional and retail channels, Quidel is better positioned to supply product in response to the recent surge in testing demand sparked by the rapid spread of the Delta variant. Consistent with our plan communicated earlier in the year, we are continuing to add manufacturing lines and are on-track to reach our target run-rate capacity of approximately 70 million rapid antigen COVID-19 tests per month by the end of the year.” Bryant continued, “One of our goals all along has been to democratize diagnostic testing and we have held true to that mission. “Customers have counted on CVS Pharmacy to provide convenient access to testing throughout the pandemic, and we look forward to removing barriers with the addition of QuickVue® At-Home to our array of trusted testing options,” said Brian Eason, Vice President, Consumer Health and Wellness, CVS Pharmacy. ![]() “We experienced a recent surge in demand for our portfolio of Sofia SARS and QuickVue COVID-19 rapid antigen tests, and adding capacity through CVS Pharmacy, a leader in providing testing access throughout the pandemic, will help address customers’ demand.” “Making QuickVue® At-Home OTC COVID-19 Tests conveniently available in-store and online at CVS Pharmacy further supports our shared commitment in meeting the testing needs of American families,” said Douglas Bryant, president and CEO of Quidel. The shelf-stable packages each contain two self-administered rapid antigen tests. SAN DIEGO-( BUSINESS WIRE)- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced in the next week it will make Quidel’s non-prescription QuickVue® At-Home OTC COVID-19 Test available to consumers at more than 7,000 CVS Pharmacy locations across the United States and online at cvs.com. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |